Skip to main content Skip to navigation
Nasal spray may ease Parkinson’s, other disease symptoms
June 16, 2016

By Lori Maricle, College of Pharmacy

Jeannie-PadowskiSPOKANE, Wash. – Researchers have reported a 240 percent increase in the brain of the antioxidant glutathione after it is administered via nasal spray. Glutathione deficiency has been documented in a variety of central nervous system disorders, including Parkinson’s disease, multiple sclerosis, autism, Alzheimer’s disease, schizophrenia and bipolar disease.